{"hands_on_practices": [{"introduction": "This exercise challenges you to think critically about the intricate sequence of events at the 26S proteasome. By considering the hypothetical inhibition of deubiquitinating enzymes (DUBs) within the 19S regulatory particle [@problem_id:2353894], you will explore why deubiquitination is a crucial step for substrate translocation into the proteolytic core. This practice moves beyond a simple 'tag-and-destroy' model to illuminate the elegant coordination required for the proteasome to function.", "problem": "In a neuroscience research lab, a novel neurotoxin called \"Stallin\" is discovered. Experiments on cultured neurons reveal that Stallin's sole mechanism of action is to potently and irreversibly inhibit the family of Deubiquitinating Enzymes (DUBs) that are integral components of the 19S regulatory particle of the 26S proteasome. The toxin has no effect on the E1, E2, or E3 enzymes responsible for attaching ubiquitin to proteins, nor does it affect the catalytic activity of the 20S core particle of the proteasome itself.\n\nAssume a healthy, functioning neuron is acutely exposed to a high concentration of Stallin. Which of the following options describes the most immediate and direct consequence for the neuron's protein degradation pathway?\n\nA. The rate of protein polyubiquitination will decrease dramatically as free ubiquitin is depleted from the cytosol.\n\nB. Polyubiquitinated proteins will be recognized by the proteasome but will become stalled at the 19S regulatory particle, unable to enter the 20S catalytic core.\n\nC. The 20S catalytic core will begin to non-selectively degrade both ubiquitinated and non-ubiquitinated proteins.\n\nD. Polyubiquitinated proteins will accumulate in the cytosol because they can no longer be recognized and bound by the 26S proteasome.", "solution": "The ubiquitin-proteasome system proceeds through these mechanistic steps: (i) E1, E2, and E3 enzymes conjugate ubiquitin to substrates, often forming polyubiquitin chains that signal degradation; (ii) the 26S proteasome, composed of the 19S regulatory particle and the 20S catalytic core, recognizes polyubiquitinated substrates via ubiquitin receptors on the 19S; (iii) the 19S uses AAA+ ATPases to unfold substrates and open the gate of the 20S core; (iv) deubiquitinating enzymes (DUBs) associated with the 19S, most critically the metalloprotease Rpn11 that is integral to the proteasome, cleave the ubiquitin chain en bloc at the substrate-ubiquitin isopeptide bond in a step that is tightly coupled to substrate engagement and translocation; (v) the substrate polypeptide is then threaded into the narrow axial pore of the 20S core for proteolysis while ubiquitin is recycled.\n\nGiven that Stallin potently and irreversibly inhibits the DUB family integral to the 19S regulatory particle, while leaving E1, E2, E3 enzymes and the 20S catalytic activity intact, the immediate consequences follow from the specific role of 19S DUBs. Recognition of polyubiquitinated proteins by the 19S ubiquitin receptors is unaffected, because Stallin does not impair ubiquitin binding modules. Likewise, the catalytic peptidase activities of the 20S core are intact, but access to the 20S requires prior, DUB-dependent removal of the ubiquitin chain at the 19S. Rpn11-mediated deubiquitination is mechanistically coupled to substrate engagement and is required to clear the ubiquitin chain so the substrate can pass through the narrow translocation channel; if DUB activity is blocked, the ubiquitin chain remains covalently attached and sterically prevents translocation into the 20S.\n\nTherefore, the most immediate and direct outcome is that polyubiquitinated substrates are still recognized and bound by the 26S proteasome but become stalled at the 19S regulatory particle because deubiquitination cannot occur, preventing entry into the 20S core. This directly corresponds to option B. Option A describes a later, indirect effect (reduced ubiquitin recycling and eventual depletion), not the immediate consequence. Option C is incorrect because the 20S core does not become non-selective simply due to 19S DUB inhibition. Option D is incorrect because recognition and binding by the proteasome are not impaired by DUB inhibition.", "answer": "$$\\boxed{B}$$", "id": "2353894"}, {"introduction": "How does a cell determine the lifespan of a protein? This problem explores the N-end rule pathway, a fascinating mechanism where a protein's stability is dictated by its N-terminal amino acid [@problem_id:2353902]. By calculating and comparing the half-life ($t_{1/2}$) of a protein fragment generated under different conditions, you will connect a specific molecular signal to a quantitative cellular outcome, honing your skills in applying first-order kinetics.", "problem": "In a model of synaptic plasticity, a neuronal transmembrane receptor, designated as Synaptic Receptor Type-C (SR-C), undergoes regulated intramembrane proteolysis. The cleavage of its single transmembrane helix by a secretase enzyme releases the SR-C Intracellular Domain (ICD) into the cytoplasm. The degradation of this soluble ICD fragment is governed by the Ubiquitin-Proteasome System (UPS), and its stability is dictated by the identity of its N-terminal amino acid, a principle known as the N-end rule pathway.\n\nThe degradation of the SR-C ICD follows first-order kinetics, where the rate constant, $k$, is determined by the N-terminal residue. The relationship is modeled as follows:\n- For N-terminal residues classified as \"stabilizing\" (e.g., Valine), the degradation rate constant is $k_{stab} = k_{base}$.\n- For N-terminal residues classified as \"primary destabilizing\" (e.g., Phenylalanine), the rate constant is modified by a destabilization factor, $\\gamma$, such that $k_{destab} = \\gamma \\cdot k_{base}$.\n\nThe secretase cleaves SR-C at one of two sites, depending on the phosphorylation state of the receptor:\n1.  Under basal neuronal activity, the secretase cleaves at Site 1, which results in the released ICD having Phenylalanine (Phe) as its N-terminal residue.\n2.  During long-term potentiation, SR-C is phosphorylated, causing the secretase to shift its cleavage to Site 2. This results in the released ICD having Valine (Val) as its N-terminal residue.\n\nGiven a base rate constant $k_{base} = 0.025 \\text{ min}^{-1}$ and a destabilization factor for Phenylalanine of $\\gamma = 5.4$, calculate the difference between the half-life of the SR-C ICD fragment generated during long-term potentiation and the half-life of the fragment generated under basal activity. Express your answer in minutes, rounded to three significant figures.", "solution": "For first-order decay, the concentration of the ICD obeys $C(t)=C_{0}\\exp(-k t)$. The half-life $t_{1/2}$ satisfies $C(t_{1/2})=C_{0}/2$, so\n$$\n\\exp(-k t_{1/2})=\\frac{1}{2}\\;\\Rightarrow\\;-k t_{1/2}=\\ln\\!\\left(\\frac{1}{2}\\right)=-\\ln 2\\;\\Rightarrow\\;t_{1/2}=\\frac{\\ln 2}{k}.\n$$\nIdentify the rate constants from the N-end rule:\n- Under long-term potentiation (LTP), the N-terminus is Val (stabilizing), so $k_{\\text{LTP}}=k_{base}$.\n- Under basal activity, the N-terminus is Phe (primary destabilizing), so $k_{\\text{basal}}=\\gamma\\,k_{base}$.\n\nThe difference in half-lives is\n$$\n\\Delta t \\equiv t_{1/2,\\text{LTP}}-t_{1/2,\\text{basal}}=\\frac{\\ln 2}{k_{base}}-\\frac{\\ln 2}{\\gamma k_{base}}=\\frac{\\ln 2}{k_{base}}\\!\\left(1-\\frac{1}{\\gamma}\\right).\n$$\nSubstitute $k_{base}=0.025\\ \\text{min}^{-1}$ and $\\gamma=5.4$. Since $\\gamma=5.4=\\frac{27}{5}$, we have $1-\\frac{1}{\\gamma}=1-\\frac{5}{27}=\\frac{22}{27}$. Therefore,\n$$\n\\Delta t=\\frac{\\ln 2}{0.025}\\cdot\\frac{22}{27}=40\\cdot\\frac{22}{27}\\,\\ln 2=\\frac{880}{27}\\,\\ln 2\\ \\text{min}\\approx 22.6\\ \\text{min},\n$$\nrounded to three significant figures.", "answer": "$$\\boxed{22.6}$$", "id": "2353902"}, {"introduction": "The ubiquitin-proteasome system is a key effector of complex signaling pathways that shape cellular function. This problem guides you in modeling how neuronal activity regulates synaptic strength by controlling the degradation of a key scaffolding protein [@problem_id:2353899]. Through steady-state analysis, you will link a signaling cascade to the activity of an E3 ligase, providing a powerful, quantitative example of the UPS's role in synaptic plasticity.", "problem": "In a model of synaptic plasticity, the structural integrity of a synapse depends on the concentration of a key scaffolding protein, denoted as $P$. The concentration of this protein, $[P]$, is dynamically regulated by its synthesis and degradation. The synthesis of $P$ occurs at a constant rate, $R_{syn}$. Its degradation is mediated by the Ubiquitin-Proteasome System (UPS).\n\nThis degradation pathway is exquisitely controlled. A specific E3 ubiquitin ligase, $L$, must be phosphorylated to become active. Let's denote the active, phosphorylated form as $L_p$ and the inactive, unphosphorylated form simply as $L$. The total concentration of this ligase, $[L_{tot}] = [L] + [L_p]$, is constant within the cell.\n\nDuring a period of sustained neuronal activity, an influx of calcium activates a specific Calcium-dependent Kinase (CaK). This active kinase phosphorylates the inactive ligase $L$ to its active form $L_p$. This phosphorylation process can be modeled with a first-order rate constant $k_{phos}$ such that the rate of formation of $L_p$ is $k_{phos}[L]$. Concurrently, a constitutively active phosphatase dephosphorylates $L_p$ back to $L$ with a first-order rate constant $k_{dephos}$, meaning the rate of this reverse reaction is $k_{dephos}[L_p]$.\n\nThe active ligase, $L_p$, then targets the scaffolding protein $P$ for degradation by the UPS. The rate of degradation of $P$ is found to be directly proportional to both the concentration of the scaffolding protein, $[P]$, and the concentration of the active ligase, $[L_p]$. This process is described by a second-order rate constant $k_{deg}$.\n\nAssuming the system is allowed to reach a new steady state under sustained neuronal activity (i.e., constant $k_{phos}$), determine the steady-state concentration of the scaffolding protein, $[P]_{ss}$. Express your answer as a single closed-form analytic expression in terms of the given parameters: $R_{syn}$, $k_{deg}$, $[L_{tot}]$, $k_{phos}$, and $k_{dephos}$.", "solution": "We model the phosphorylation-dephosphorylation cycle for the ligase as a two-state system with total ligase conserved. Denote the inactive form concentration by $[L]$ and the active phosphorylated form by $[L_{p}]$, with $[L_{tot}] = [L] + [L_{p}]$ constant. The kinetics are first order:\n$$\n\\frac{d[L_{p}]}{dt} = k_{phos}[L] - k_{dephos}[L_{p}] \\, .\n$$\nUsing conservation, $[L] = [L_{tot}] - [L_{p}]$, so\n$$\n\\frac{d[L_{p}]}{dt} = k_{phos}\\left([L_{tot}] - [L_{p}]\\right) - k_{dephos}[L_{p}] \\, .\n$$\nAt steady state under sustained activity, set $\\frac{d[L_{p}]}{dt} = 0$:\n$$\n0 = k_{phos}[L_{tot}] - \\left(k_{phos} + k_{dephos}\\right)[L_{p}] \\, ,\n$$\nwhich gives\n$$\n[L_{p}]_{ss} = \\frac{k_{phos}}{k_{phos} + k_{dephos}}[L_{tot}] \\, .\n$$\n\nThe scaffolding protein $P$ is synthesized at a constant rate $R_{syn}$ and degraded with second-order kinetics proportional to $[P][L_{p}]$ with rate constant $k_{deg}$. Its dynamics are\n$$\n\\frac{d[P]}{dt} = R_{syn} - k_{deg}[P][L_{p}] \\, .\n$$\nAt steady state,\n$$\n0 = R_{syn} - k_{deg}[P]_{ss}[L_{p}]_{ss} \\quad \\Rightarrow \\quad [P]_{ss} = \\frac{R_{syn}}{k_{deg}[L_{p}]_{ss}} \\, .\n$$\nSubstituting the steady-state active ligase concentration,\n$$\n[P]_{ss} = \\frac{R_{syn}}{k_{deg}\\left(\\frac{k_{phos}}{k_{phos} + k_{dephos}}[L_{tot}]\\right)} = \\frac{R_{syn}\\left(k_{phos} + k_{dephos}\\right)}{k_{deg} \\, k_{phos} \\, [L_{tot}]} \\, .\n$$\nThis is the required closed-form expression in terms of the given parameters.", "answer": "$$\\boxed{\\frac{R_{syn}\\left(k_{phos}+k_{dephos}\\right)}{k_{deg}\\,k_{phos}\\,[L_{tot}]}}$$", "id": "2353899"}]}